Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients Clinical research trials and The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients. The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients clinical trial. Participants typically obtain the most effective healthcare available for their The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.

Home > "T" Clinical Trials Conditions > The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients

The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients



The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients

For Condition: HIV Infections
Status: Completed
Sponsor(s): Mucos Pharma GmbH and Co ,
Synopsis: To study the safety and efficacy of four different doses of Wobenzym (an enzyme combination consisting of pancreatin, papain, bromelain, trypsin, lipase, amylase, chymotrypsin, and rutin) in patients with HIV infection whose CD4 count is between 250 and 400 cells/mm3. To evaluate the effect of Wobenzym on certain surrogate markers associated with progression of HIV disease.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Dose Comparison, Pharmacokinetics Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: HIV seropositivity with CD4 counts between 250 and 400 cells/mm3. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Known hypersensitivity to hydrolytic enzymes such as Wobenzym. - Known sensitivity to lactose. - Presumption that the patient will not comply with the dosing schedule or follow-up appointments. Concurrent Medication: Excluded: - Concurrent use of immunosuppressive therapy or steroids.
Total Enrollment: 

Location and Contact Information:

Saint Luke's - Roosevelt Hosp Ctr
New York City,  New York,  10019
United States
 


Additional Information:
Study ID Numbers:
  122A; 
Study Start Date: 
Record last reviewed: May 1993
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002311

Other Hiv Infections Studies:
1. A Multi-Center Randomized Double-Blind Placebo-Controlled Study To Investigate the Effect of Isoprinosine in Immunodepressed Patients With Uncomplicated Generalized Lymphadenopathy

2. A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

3. A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

4. A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected Patients

5. A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain

Related Studies:

Other HIV Infections Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials

The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients

Modify your Search

  Other HIV Infections Clinical Trials
  Other New York Clinical Trials
  Other New York City Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103